AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Robert A. Michael
CEORobert A. Michael
Employees
55,000
Employees55,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
55,000
Employees55,000

ABBV Key Statistics

Market cap
382.83B
Market cap382.83B
Price-Earnings ratio
167.43
Price-Earnings ratio167.43
Dividend yield
2.96%
Dividend yield2.96%
Average volume
7.50M
Average volume7.50M
High today
$217.35
High today$217.35
Low today
$214.27
Low today$214.27
Open price
$215.26
Open price$215.26
Volume
2.66M
Volume2.66M
52 Week high
$244.81
52 Week high$244.81
52 Week low
$164.39
52 Week low$164.39

Stock Snapshot

AbbVie(ABBV) stock is priced at $216.61, giving the company a market capitalization of 382.83B. It carries a P/E multiple of 167.43 and pays a dividend yield of 3.0%.

As of 2026-01-16, AbbVie(ABBV) stock has fluctuated between $214.27 and $217.35. The current price stands at $216.61, placing the stock +1.1% above today's low and -0.3% off the high.

The AbbVie(ABBV)'s current trading volume is 2.66M, compared to an average daily volume of 7.5M.

In the last year, AbbVie(ABBV) shares hit a 52-week high of $244.81 and a 52-week low of $164.39.

In the last year, AbbVie(ABBV) shares hit a 52-week high of $244.81 and a 52-week low of $164.39.

ABBV News

TipRanks 10m
AbbVie Expands Oncology Pipeline With First-in-Human ABBV-711 Trial in Advanced Squamous Tumors

Abbvie (ABBV) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for...

Simply Wall St 3h
How Investors May Respond To AbbVie $100 Billion U.S. Investment And Drug Pricing Pact

In recent days, AbbVie said it reached a voluntary three-year agreement with the Trump administration to cut prices on select medicines offered through Medicaid...

How Investors May Respond To AbbVie $100 Billion U.S. Investment And Drug Pricing Pact
Nasdaq 18h
AbbVie Stock Dips While Market Gains: Key Facts

The latest trading session saw AbbVie (ABBV) ending at $193.45, denoting a -1.16% adjustment from its last day's close. This move lagged the S&P 500's daily gai...

AbbVie Stock Dips While Market Gains: Key Facts

Analyst ratings

65%

of 31 ratings
Buy
64.5%
Hold
32.3%
Sell
3.2%

More ABBV News

TipRanks 1d
AbbVie Advances Obesity Pipeline With Completion of First-in-Human GUB014295 Trial

Abbvie (ABBV) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for...

Simply Wall St 2d
Assessing AbbVie Valuation After Recent Share Price Weakness

Advertisement Event driven look at AbbVie AbbVie (ABBV) has been drawing attention after recent share price moves, with the stock modestly positive over the p...

Assessing AbbVie Valuation After Recent Share Price Weakness
Nasdaq 2d
Ex-Dividend Reminder: AbbVie, Dime Community Bancshares and MidWestOne Financial Group

Looking at the universe of stocks we cover at Dividend Channel, on 1/16/26, AbbVie Inc (Symbol: ABBV), Dime Community Bancshares Inc (Symbol: DCOM), and MidWest...

Ex-Dividend Reminder: AbbVie, Dime Community Bancshares and MidWestOne Financial Group
Benzinga 3d
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines

AbbVie Inc. (NYSE:ABBV) on Monday announced a voluntary agreement with the Trump administration to advance access and affordability further. AbbVie said it wil...

AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines
Simply Wall St 4d
Is AbbVie Pricing Look Attractive After Strong Multi Year Share Gains

If you are wondering whether AbbVie’s current share price reflects its underlying value, you are not alone. This article will walk through what the market might...

Is AbbVie Pricing Look Attractive After Strong Multi Year Share Gains
The Wall Street Journal 4d
AbbVie Strikes $100 Billion Investment Deal With Trump, Will Lower Medicaid Prices

AbbVie also plans to expand direct-to-patient offerings through the government portal TrumpRx for some medicines. Clodagh Kilcoyne/Reuters AbbVie ABBV -0.02 %d...

AbbVie Strikes $100 Billion Investment Deal With Trump, Will Lower Medicaid Prices
TipRanks 4d
AbbVie announces voluntary agreement with the Trump administration

AbbVie (ABBV) announced a voluntary agreement with the Trump administration to further advance access and affordability for Americans while protecting and inves...

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .